Sort
23,748 grants matching “melanoma”
IMMUNIZATION AGAINST MELANOMA DIFFERENTIATION ANTIGENS
$233,176Sloan-Kettering Institute For Cancer Res · R01 · FY2000 · CA
CANCER AND LEUKEMIA GROUP B--PET COMMITTEE
$233,136University Of Chicago · U10 · FY2002 · CA
Human Immunology Core
$233,065Eline Tjetske Luning Prak · University Of Pennsylvania · P30 · FY2018 · CA
Carbohydrate- Dependent Epithelial Cancer Metastasis
$233,030Michiko N Fukuda · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2010 · CA
Ceramide Production in Photosensitized Apoptotic Cells
$232,973Duska M Separovic · Wayne State University · R01 · FY2006 · CA
TDG as a novel target to enhance gemcitabine killing of pancreatic cancer cells
$232,943Alfonso Bellacosa · Research Inst Of Fox Chase Can Ctr · R21 · FY2015 · CA
STAT5: ROLE IN CTL DEVELOPMENT AND ONCOGENESIS
$232,892John A Kelly · Dartmouth College · P20 · FY2007 · RR
A Small Molecule to Activate Tumor Immunity after PLX403 in V600E BRAF Melanoma
$232,852Barry Jones · Arisaph Pharmaceuticals, Inc. · R41 · FY2013 · CA
Abrogation of Therapeutic Escape Pathways in BRAF Mutant Melanoma
$232,736Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2017 · CA
Cancer and Leukemia Group B
$232,702Richard L Schilsky · University Of Chicago · U10 · FY2009 · CA
The Etiology of UV-Induced Melanoma
$232,676David L Mitchell · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · CA
The Etiology of UV-Induced Melanoma
$232,676David L Mitchell · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · CA
The Etiology of UV-Induced Melanoma
$232,676David L Mitchell · University Of Tx Md Anderson Can Ctr · R01 · FY2008 · CA
The Etiology of UV-Induced Melanoma
$232,676David L Mitchell · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · CA
Potentiating the Effects of Targeted and Cytotoxic Agents on Cell-Based Immunoth
$232,673Dmitry Isaac Gabrilovich · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2016 · CA
Metabolic Engineering of Cancer for Selective Immunotargeting
$232,622Zhongwu Guo · Wayne State University · R01 · FY2014 · CA
Metabolic Engineering of Cancer for Selective Immunotargeting
$232,622Zhongwu Guo · Wayne State University · R01 · FY2015 · CA
PDGF REGULATES VITRONECTIN BINDING INTEGRINS IN ASTROCYTOMA
$232,605University Of Alabama At Birmingham · P01 · FY2000 · NS
Core D: Medicinal Chemistry Core
$232,523Meenhard Herlyn · Wistar Institute · P01 · FY2013 · CA
ABCB5 and Melanoma Stem Cells: Implications for Prognosis & Therapeutic Targeting
$232,504Frank Markus · Brigham And Women'S Hospital · P50 · FY2012 · CA
PKCalpha-Mediated Mechanisms in Metastatic Melanoma
$232,500Susan A. Rotenberg · Queens College · R15 · FY2007 · CA
Enhancing the Efficacy of T-cells and immunotherapies by precision targeting of Nrf2 using PROTACs
$232,500Kalyani Pyaram · University Of Kansas Medical Center · P20 · FY2025 · GM
An Intelligent Melanoma Diagnostic Training System
$232,489University Of Pittsburgh At Pittsburgh · R25 · FY2003 · CA
Analytical Chemistry and Pharmacology Core Facility
$232,443William C Zamboni · Univ Of North Carolina Chapel Hill · P30 · FY2015 · CA
Regulators of Translation Elongation Factor eEF1A
$232,397Terri Goss Kinzy · Western Michigan University · R01 · FY2017 · GM